Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results
Journal of Market Access & Health Policy
doi 10.1080/20016689.2019.1648973
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Informa UK Limited